Log In
BCIQ
Print this Print this
 

CGEN-15091

  Manage Alerts
Collapse Summary General Information
Company Compugen Ltd.
DescriptionFusion protein combining an Fc antibody fragment with the extracellular region of a previously unknown membrane protein in the B7/CD28 family
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today